User:Kgenn001/A20 cells

Lead
A20 cells, also called ATCC TIB-208, are BALB/c lymphoma cells derived from spontaneous reticulum cell neoplasm. ATCC TIB-208 cells originated from B-cell lymphoma in the reticulum cell sarcoma of an elderly BALB/c mouse. A20 cells are highly responsive to immunomodulatory antibodies, and are therefore used frequently in immunotherapy drug studies. A20 cells are also used in medical research such as drug screening or vaccine target selection.